Read + Share
Amedeo Smart
Independent Medical Education
Douglas RS, Kahaly GJ. Teprotumumab for Active Thyroid Eye Disease. Reply. N Engl J Med 2020;382:1959-1960.PMID: 32402172
Email
LinkedIn
Facebook
Twitter
Privacy Policy